Favorable Outcomes Following the Use of Triple Therapy in a Patient with Osmotic Demyelination Syndrome

Autores/as

  • Chisom Eze
  • Yasmine Hussein Agha
  • Brent Duran

DOI:

https://doi.org/10.17161/kjm.v13i.13875

Palabras clave:

central pontine myelinolysis, hyponatremia, plasmapheresis, immune globulin intravenous (human)

Descargas

Publicado

2020-07-10

Número

Vol. 13 (2020)

Sección

Case Reports

Licencia

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

Cómo citar

Eze, C., Hussein Agha, Y., & Duran, B. (2020). Favorable Outcomes Following the Use of Triple Therapy in a Patient with Osmotic Demyelination Syndrome. Kansas Journal of Medicine, 13(1), 191-193. https://doi.org/10.17161/kjm.v13i.13875